1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2018-2029)
2.2 Adoptive Cell Therapy Growth Trends by Region
2.2.1 Adoptive Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Adoptive Cell Therapy Market Dynamics
2.3.1 Adoptive Cell Therapy Industry Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2022
3.5 Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2029)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2018-2029)
6.2 North America Adoptive Cell Therapy Market Size by Country (2018-2023)
6.3 North America Adoptive Cell Therapy Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2018-2029)
7.2 Europe Adoptive Cell Therapy Market Size by Country (2018-2023)
7.3 Europe Adoptive Cell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size (2018-2029)
9.2 Latin America Adoptive Cell Therapy Market Size by Country (2018-2023)
9.3 Latin America Adoptive Cell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Juno
11.2.1 Juno Company Detail
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2018-2023)
11.2.5 Juno Recent Development
11.3 Kite
11.3.1 Kite Company Detail
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2018-2023)
11.3.5 Kite Recent Development
11.4 Adaptimmune
11.4.1 Adaptimmune Company Detail
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2018-2023)
11.4.5 Adaptimmune Recent Development
11.5 Fibrocell
11.5.1 Fibrocell Company Detail
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2018-2023)
11.5.5 Fibrocell Recent Development
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Detail
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.6.5 Lineage Cell Therapeutics Recent Development
11.7 BioTime
11.7.1 BioTime Company Detail
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2018-2023)
11.7.5 BioTime Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2018-2023)
11.8.5 Vericel Corporation Recent Development
11.9 Regeneus
11.9.1 Regeneus Company Detail
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2018-2023)
11.9.5 Regeneus Recent Development
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Detail
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2018-2023)
11.10.5 Anhui Anke Biotechnology Recent Development
11.11 Cellectis
11.11.1 Cellectis Company Detail
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.11.5 Cellectis Recent Development
11.12 NantKwest
11.12.1 NantKwest Company Detail
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2018-2023)
11.12.5 NantKwest Recent Development
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Detail
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.13.5 SorrentoTherapeutics Recent Development
11.14 Bellicum
11.14.1 Bellicum Company Detail
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2018-2023)
11.14.5 Bellicum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
